Ekso Bionics EksoNR
by Ekso Bionics
$100,000 - $150,000
The Ekso Bionics EksoNR is the clinical gold standard for robotic gait rehabilitation, FDA-cleared for use with stroke and spinal cord injury patients. EksoNR's SmartAssist technology allows therapists to set variable assistance levels for each leg and adjust in real-time during therapy sessions, providing precise control over the rehabilitation process. At $100,000–$150,000, EksoNR commands a significant premium over Chinese alternatives but is backed by extensive clinical evidence, FDA clearance, and a global installed base of over 400 rehabilitation centers. Ekso Bionics has collected data from over 200 million exoskeleton-assisted steps, providing the deepest clinical insights in the industry. EksoNR is the benchmark against which all rehabilitation exoskeletons are compared.
Applications
Specifications
| type | Powered lower-limb |
| weight | 25kg |
| battery_life | 3 hours |
| max_user_weight | 100kg |
| walking_speed | 0-1.6 km/h |
| dof | 8 (hip, knee bilateral) |
| certifications | FDA cleared, CE marked |
Key Features
FDA-cleared for stroke and spinal cord injury rehabilitation
SmartAssist variable assist technology
Real-time gait analytics and reporting
Touchscreen clinical interface
Multiple gait modes (first step, pro step, free walk)
Compatible with body-weight support systems
Over 200 million steps data collected globally
Use Cases
Inpatient stroke rehabilitation
Spinal cord injury gait training
Traumatic brain injury recovery
Multiple sclerosis mobility therapy
Clinical research studies
Related Products
Get a Free Quote
Fill out the form below and we'll connect you with verified manufacturers within 24 hours.